Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05796492Not ApplicableTerminated

Ultrasound Treatment on Wound Healing Time

Role: lead

NCT04701489Not ApplicableCompleted

UNITE Study (UMN-GE) for COVID-19

Role: collaborator

NCT04502212Not ApplicableCompleted

Pilot Study to Assess the Effects of Hepatic Ultrasound Insonification on Subjects With T2DM

Role: lead

All 3 trials loaded